Machine learning-based analysis of multi-parametric was used to predict pathological outcome of biopsy-proven Gleason score 3+3 prostate cancer and proven to be better compared with single any MR or clinical paremeter in predicting pathological outcome.
This abstract and the presentation materials are available to members only; a login is required.